Commission Implementing Decision (EU) 2022/1496 of 8 September 2022 postponing the expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

CELEX: 32022D1496
Document type: DEC_IMPL
Sector: Legislation
Date of document: 2022-09-08
In force since: 2022-09-29
Status: In force
ELI: http://data.europa.eu/eli/dec_impl/2022/1496/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

The expiry date of the approval of tebuconazole for use in biocidal products of product-type 8 set out in Implementing Decision (EU) 2019/1951 is postponed to 30 June 2026.

Article 2

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions